Hochhaus, Andreas
Gambacorti-Passerini, Carlo
Abboud, Camille
Gjertsen, Bjørn Tore
Brümmendorf, Tim H.
Smith, B. Douglas
Ernst, Thomas
Giraldo-Castellano, Pilar
Olsson-Strömberg, Ulla
Saussele, Susanne
Bardy-Bouxin, Nathalie
Viqueira, Andrea
Leip, Eric
Russell-Smith, T. Alexander
Leone, Jocelyn
Rosti, Gianantonio
Watts, Justin
Giles, Francis J.
Abruzzese, E.
Akard, L. P.
Bosi, A.
Cervantes, F.
Charbonnier, A.
Di Raimondo, F.
Etienne, G.
Garcia Gutierrez, V.
Guerci-Bresler, A. P.
Hjorth-Hansen, H
Karsenti, J. M.
Kelly, K. R.
Le Coutre, P.
Martinez Chamorro, C.
Oehler, V. G.
Orti Pascual, G.
Petzer, A.
Pungolino, E.
Rege-Cambrin, G.
Rigal-Huguet, F.
Roboz, G. J.
Rousselot, P.
Sanchez-Guijo, F. M.
Sanz Santillana, G.
Schafhausen, P.
Scheid, C.
Schmidt, S.
Specchia, G.
Steegmann, J. L.
Stenke, L.
,
Funding for this research was provided by:
Pfizer
Article History
Received: 25 May 2020
Revised: 1 June 2020
Accepted: 4 June 2020
First Online: 22 June 2020
Compliance with ethical standards
:
: Authors declare the following potential conflicts of interest: AH received honoraria from BMS, Novartis, Pfizer, and Takeda, and received research support from BMS, Incyte, Novartis, and Pfizer. CGP provides consultancy to BMS and received honoraria and research support from Pfizer. CA serves on the advisory board for Archer DX, Jazz Pharma, and Tetraphase Pharma, provides consultancy to Actinium, Agios, Bayer, Cardinal Health, Gerson Lehman Group, Incyte, Jazz Pharma, NKarta, Pfizer, Seattle Genetics, and Tetraphase Pharma, received honoraria from Agios, Cardinal Health, and Jazz Pharma, received research support from Pfizer, and serves on the speakers bureau for Jazz Pharma / provides expert testimony for Dava Oncology. BTG is a consultant for BerGenBio, Novartis, Pfizer, and Sanofi Genzyme, received research support from Pfizer, and has stock ownership in Alden Cancer Therapy AS and KinN Therapeutics AS. THB is a consultant for Janssen, Merck, Novartis, Pfizer, and Takeda, and received research support from Novartis and Pfizer. BDS received honoraria for consulting to Agios, Celgene, Jazz Pharma, Novartis and Pfizer, and received research support from Pfizer. PGC received research support from BMS and Pfizer. UOS received research support from Pfizer. SS received honoraria from BMS, Incyte, Novartis, and Pfizer, and received research support from BMS, Incyte, Novartis, and Pfizer. TE received research support from BMS, Incyte, Novartis, and Pfizer. NBB, AV, EL, ARS and JL are employees of Pfizer. GR received research support from Pfizer and served on the speaker bureau for BMS, Incyte, Novartis, and Pfizer. JW serves on the advisory board for Jazz Pharma and Takeda, received research support from Pfizer and Takeda, and serves on the data monitoring committee for Rafael Pharma. FJG is a consultant to Actuate Therapeutics Inc, provides expert testimony to Novartis, and received research support from Pfizer.
: Upon request, and subject to certain criteria, conditions and exceptions (see ExternalRef removed for more information), Pfizer will provide access to individual de-identified participant data from Pfizer-sponsored global interventional clinical studies conducted for medicines, vaccines and medical devices (1) for indications that have been approved in the USA and/or Europe or (2) in programs that have been terminated (i.e., development for all indications has been discontinued). Pfizer will also consider requests for the protocol, data dictionary, and statistical analysis plan. Data may be requested from Pfizer trials 24 months after study completion. The de-identified participant data will be made available to researchers whose proposals meet the research criteria and other conditions, and for which an exception does not apply, via a secure portal. To gain access, data requestors must enter into a data access agreement with Pfizer.